1. MicroRNA: potential biomarkers and therapeutic targets for allergic asthma?

    Annals of Medicine 46(8):633 (2014) PMID 25307360

    MicroRNAs are small non-coding RNAs that bind to multiple target mRNAs to control gene expression post-transcriptionally by inhibiting translation. In mammalian cells, microRNAs play important roles in a diverse array of cellular processes (e.g. cell proliferation and differentiation). However, ...
  2. MicroRNA: Potential biomarkers and therapeutic targets for allergic asthma?

    Annals of Medicine 46(8):633 (2014) PMID 25307360

    Abstract MicroRNAs are small non-coding RNAs that bind to multiple target mRNAs to control gene expression post-transcriptionally by inhibiting translation. In mammalian cells, microRNAs play important roles in a diverse array of cellular processes (e.g. cell proliferation and differentiation). ...
  3. Tumor necrosis factor-related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease.

    American Journal of Respiratory Cell and Molecu... 51(1):86 (2014) PMID 24484417

    Allergic asthma is a complex disease characterized by acute inflammation of the airways that over time leads to the development of significant structural changes termed remodeling. TNF-related apoptosis-inducing ligand (TRAIL) has an important regulatory role in acute allergic airways inflammati...
  4. Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A.

    Journal of Allergy and Clinical Immunology 133(6):1720 (2014) PMID 24388637

    β-Agonists are used for relief and control of asthma symptoms by reversing bronchoconstriction. They might also have anti-inflammatory properties, but the underpinning mechanisms remain poorly understood. Recently, a direct interaction between formoterol and protein phosphatase 2A (PP2A) has bee...
  5. Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A.

    Journal of Allergy and Clinical Immunology 133(6):1720 (2014) PMID 24388637

    β-Agonists are used for relief and control of asthma symptoms by reversing bronchoconstriction. They might also have anti-inflammatory properties, but the underpinning mechanisms remain poorly understood. Recently, a direct interaction between formoterol and protein phosphatase 2A (PP2A) has bee...
  6. Absence of Toll-IL-1 receptor 8/single immunoglobulin IL-1 receptor-related molecule reduces house dust mite-induced allergic airway inflammation in mice.

    American Journal of Respiratory Cell and Molecu... 49(3):481 (2013) PMID 23614768

    Allergic asthma is a chronic inflammatory disease predominately associated with the activation of CD4(+) T helper Type 2 (Th2) cells. Innate pattern recognition receptors are widely acknowledged to shape the adaptive immune response. For example, the activation of airway epithelial Toll-like rec...
  7. Epigenetic changes associated with disease progression in a mouse model of childhood allergic asthma.

    Disease Models & Mechanisms 6(4):993 (2013) PMID 23611895 PMCID PMC3701218

    Development of asthma in childhood is linked to viral infections of the lower respiratory tract in early life, with subsequent chronic exposure to allergens. Progression to persistent asthma is associated with a Th2-biased immunological response and structural remodelling of the airways. The und...
  8. The emerging role of microRNAs in regulating immune and inflammatory responses in the lung.

    Immunological Reviews 253(1):198 (2013) PMID 23550648

    Chronic inflammatory diseases of the lung are leading causes of morbidity and mortality worldwide. Many of these disorders can be attributed to abnormal immune responses to environmental stimuli and infections. As such, understanding the innate host defense pathways and their regulatory systems ...
  9. The emerging role of microRNAs in regulating immune and inflammatory responses in the lung.

    Immunological Reviews 253(1):198 (2013) PMID 23550648

    Chronic inflammatory diseases of the lung are leading causes of morbidity and mortality worldwide. Many of these disorders can be attributed to abnormal immune responses to environmental stimuli and infections. As such, understanding the innate host defense pathways and their regulatory systems ...
  10. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity.

    Nature Medicine 19(2):232 (2013) PMID 23334847

    Allergic airway inflammation is associated with activation of innate immune pathways by allergens. Acute exacerbations of asthma are commonly associated with rhinovirus infection. Here we show that, after exposure to house dust mite (HDM) or rhinovirus infection, the E3 ubiquitin ligase midline ...
  11. Inhibiting AKT phosphorylation employing non-cytotoxic anthraquinones ameliorates TH2 mediated allergic airways disease and rhinovirus exacerbation.

    PLoS ONE 8(11):e79565 (2013) PMID 24223970 PMCID PMC3818233

    Severe asthma is associated with T helper (TH) 2 and 17 cell activation, airway neutrophilia and phosphoinositide-3-kinase (PI3K) activation. Asthma exacerbations are commonly caused by rhinovirus (RV) and also associated with PI3K-driven inflammation. Anthraquinone derivatives have been shown t...
  12. Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating PP2A

    Journal of Allergy and Clinical Immunology (2012)

    Background Beta agonists are used for relief and control of asthma symptoms by reversing bronchoconstriction. They may also have anti-inflammatory properties but the underpinning mechanisms remain poorly understood. Recently, a direct interaction between formoterol and protei...
  13. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment.

    Journal of Allergy and Clinical Immunology 128(1):160 (2011) PMID 21571357

    Glucocorticoids are used as mainstay therapy for asthma, but some patients remain resistant to therapy. MicroRNAs (miRNAs) are important regulators of the immune system by promoting the catabolism of their target transcripts as well as attenuating their translation. The role of miRNA in regulati...
  14. Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target.

    BMC Pulmonary Medicine 11:29 (2011) PMID 21605405 PMCID PMC3116478

    The role of microRNAs (miRNAs) in regulating gene expression is currently an area of intense interest. Relatively little is known, however, about the role of miRNAs in inflammatory and immunologically-driven disorders. In a mouse model, we have previously shown that miRNAs are potentially import...
  15. Inhibition of house dust mite–induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment

    Journal of Allergy and Clinical Immunology 128(1):160 (2011)

    Background Glucocorticoids are used as mainstay therapy for asthma, but some patients remain resistant to therapy. MicroRNAs (miRNAs) are important regulators of the immune system by promoting the catabolism of their target transcripts as well as attenuating their translation. The role...
  16. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease.

    PNAS 106(44):18704 (2009) PMID 19843690 PMCID PMC2773983

    Allergic asthma is an inflammatory disease of the lung characterized by abnormal T helper-2 (T(H)2) lymphocyte responses to inhaled antigens. The molecular mechanisms leading to the generation of T(H)2 responses remain unclear, although toll-like receptors (TLRs) present on innate immune cells p...
  17. Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses.

    Clinical and Experimental Pharmacology and Phys... 36(11):1049 (2009) PMID 19656161

    1. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in tumour cells while leaving most non-transformed cells unharmed. Binding of TRAIL to its death receptors (DR4 and DR5) activates the extrinsic apoptotic pathway by recruiting procaspase 8 into the death-induc...
  18. Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses.

    American Journal of Respiratory and Critical Ca... 179(10):883 (2009) PMID 19246719

    One of the immunopathological features of allergic inflammation is the infiltration of helper T type 2 (Th2) cells to the site of disease. Activation of innate pattern recognition receptors such as Toll-like receptors (TLRs) plays a critical role in helper T type 1 cell differentiation, yet thei...
  19. Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation.

    Current Opinion in Molecular Therapeutics 10(2):150 (2008) PMID 18386227

    Micro (mi)RNAs are small, regulatory RNA molecules that are integral components of the genetic program in the majority of cells. They are thought to regulate up to one third of all human genes and have been linked to critical processes in disease pathogenesis. The diverse role of miRNAs in disea...
  20. Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease.

    Nature Medicine 13(11):1308 (2007) PMID 17934471

    The role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in immune responses mediated by T-helper 2 (T(H)2) lymphocytes is unknown. Here we characterize the development of allergic airway disease in TRAIL-deficient (Tnfsf10(-/-)) mice and in mice exposed to short interfering R...